The board of directors of China Health Group Limited announced that with effect from 8 March 2021, Mr. Weng Yu (Mr. Weng) has resigned as the non-executive Director of the company due to his other personal pursuits and business commitments and ceased to act as the authorised representative of the Company under Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited. The Board further announces that Mr. Chung Ho, the executive Director of the Company, has been appointed as the authorized representative of the Company under Rule 3.05 of the Listing Rules in replacement of Mr. Weng with effect from 8 March 2021.